Follow this preprint
Adjusting for medication status in genome-wide association studies
View ORCID ProfileAmanda H.W. Chong, View ORCID ProfileChristopher Kintu, Yoonsu Cho, View ORCID ProfileSegun Fatumo, Jason Torres, View ORCID ProfileGeorge Davey Smith, View ORCID ProfileTom R. Gaunt, View ORCID ProfileGibran Hemani
doi: https://doi.org/10.1101/2024.02.19.24303028
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Amanda H.W. Chong
1MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Christopher Kintu
2MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda
Yoonsu Cho
1MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
Segun Fatumo
2MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda
3Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK
Jason Torres
4Medical Research Council Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
George Davey Smith
1MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
4Medical Research Council Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
Tom R. Gaunt
1MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
5NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol
Gibran Hemani
1MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
5NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol

Data availability
All scripts used to perform these analyses are available at https://github.com/MRCIEU/bp-drug-mr/tree/main/analysis/gwas/ldlc_adj_med_analysis.
Posted February 20, 2024.
Adjusting for medication status in genome-wide association studies
Amanda H.W. Chong, Christopher Kintu, Yoonsu Cho, Segun Fatumo, Jason Torres, George Davey Smith, Tom R. Gaunt, Gibran Hemani
medRxiv 2024.02.19.24303028; doi: https://doi.org/10.1101/2024.02.19.24303028
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (419)
- Allergy and Immunology (741)
- Anesthesia (217)
- Cardiovascular Medicine (3193)
- Dermatology (270)
- Emergency Medicine (473)
- Epidemiology (13180)
- Forensic Medicine (19)
- Gastroenterology (883)
- Genetic and Genomic Medicine (5011)
- Geriatric Medicine (467)
- Health Economics (767)
- Health Informatics (3154)
- Health Policy (1119)
- Hematology (418)
- HIV/AIDS (992)
- Medical Education (466)
- Medical Ethics (123)
- Nephrology (512)
- Neurology (4764)
- Nursing (253)
- Nutrition (706)
- Oncology (2452)
- Ophthalmology (696)
- Orthopedics (274)
- Otolaryngology (335)
- Pain Medicine (317)
- Palliative Medicine (89)
- Pathology (525)
- Pediatrics (1270)
- Primary Care Research (542)
- Public and Global Health (7325)
- Radiology and Imaging (1647)
- Respiratory Medicine (959)
- Rheumatology (469)
- Sports Medicine (413)
- Surgery (531)
- Toxicology (68)
- Transplantation (227)
- Urology (197)